Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Oct 15;93(21):11421–11425. doi: 10.1073/pnas.93.21.11421

Fusigenic viral liposome for gene therapy in cardiovascular diseases.

V J Dzau 1, M J Mann 1, R Morishita 1, Y Kaneda 1
PMCID: PMC38072  PMID: 8876150

Abstract

To improve the efficiency of liposome-mediated DNA transfer as a tool for gene therapy, we have developed a fusigenic liposome vector based on principles of viral cell fusion. The fusion proteins of hemagglutinating virus of Japan (HVJ; also Sendai virus) are complexed with liposomes that encapsulate oligodeoxynucleotide or plasmid DNA. Subsequent fusion of HVJ-liposomes with plasma membranes introduces the DNA directly into the cytoplasm. In addition, a DNA-binding nuclear protein is incorporated into the HVJ-liposome particle to enhance plasmid transgene expression. The fusigenic viral liposome vector has proven to be efficient for the intracellular introduction of oligodeoxynucleotide, as well as intact genes up to 100 kbp, both in vitro and in vivo. Many animal tissues have been found to be suitable targets for fusigenic viral liposome DNA transfer. In the cardiovascular system, we have documented successful cytostatic gene therapy in models of vascular proliferative disease using antisense oligodeoxynucleotides against cell cycle genes, double-stranded oligodeoxynucleotides as "decoys" to trap the transcription factor E2F, and expression of a transgene encoding the constitutive endothelial cell form of nitric oxide synthase. Similar strategies are also effective for the genetic engineering of vein grafts and for the treatment of a mouse model of immune-mediated glomerular disease.

Full text

PDF
11421

Images in this article

11423Fig. 2
on p.11423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng L., Ziegelhoffer P. R., Yang N. S. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4455–4459. doi: 10.1073/pnas.90.10.4455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hopkins N. High titers of retrovirus (vesicular stomatitis virus) pseudotypes, at last. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8759–8760. doi: 10.1073/pnas.90.19.8759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 1989 Jan 20;243(4889):375–378. doi: 10.1126/science.2911748. [DOI] [PubMed] [Google Scholar]
  4. Kaneda Y., Iwai K., Uchida T. Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem. 1989 Jul 25;264(21):12126–12129. [PubMed] [Google Scholar]
  5. Kaneda Y., Morishita R., Tomita N. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. J Mol Med (Berl) 1995 Jun;73(6):289–297. doi: 10.1007/BF00231615. [DOI] [PubMed] [Google Scholar]
  6. Kaneda Y., Uchida T., Kim J., Ishiura M., Okada Y. The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides. Exp Cell Res. 1987 Nov;173(1):56–69. doi: 10.1016/0014-4827(87)90331-4. [DOI] [PubMed] [Google Scholar]
  7. Lilley D. M. DNA--protein interactions. HMG has DNA wrapped up. Nature. 1992 May 28;357(6376):282–283. doi: 10.1038/357282a0. [DOI] [PubMed] [Google Scholar]
  8. Mann M. J., Gibbons G. H., Kernoff R. S., Diet F. P., Tsao P. S., Cooke J. P., Kaneda Y., Dzau V. J. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4502–4506. doi: 10.1073/pnas.92.10.4502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Marshall E. Gene therapy's growing pains. Science. 1995 Aug 25;269(5227):1050, 1052-5. doi: 10.1126/science.7652552. [DOI] [PubMed] [Google Scholar]
  10. Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474–8478. doi: 10.1073/pnas.90.18.8474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., von der Leyen H., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994 Apr;93(4):1458–1464. doi: 10.1172/JCI117123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morishita R., Gibbons G. H., Horiuchi M., Ellison K. E., Nakama M., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5855–5859. doi: 10.1073/pnas.92.13.5855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nakanishi M., Uchida T., Sugawa H., Ishiura M., Okada Y. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus). Exp Cell Res. 1985 Aug;159(2):399–409. doi: 10.1016/s0014-4827(85)80013-6. [DOI] [PubMed] [Google Scholar]
  14. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996 Apr 12;272(5259):263–267. doi: 10.1126/science.272.5259.263. [DOI] [PubMed] [Google Scholar]
  15. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol. 1993;221:18–41. doi: 10.1016/0076-6879(93)21005-s. [DOI] [PubMed] [Google Scholar]
  16. Remy J. S., Kichler A., Mordvinov V., Schuber F., Behr J. P. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1744–1748. doi: 10.1073/pnas.92.5.1744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sugawa H., Uchida T., Yoneda Y., Ishiura M., Okada Y. Large macromolecules can be introduced into cultured mammalian cells using erythrocyte membrane vesicles. Exp Cell Res. 1985 Aug;159(2):410–418. doi: 10.1016/s0014-4827(85)80014-8. [DOI] [PubMed] [Google Scholar]
  18. Sugden B., Marsh K., Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol. 1985 Feb;5(2):410–413. doi: 10.1128/mcb.5.2.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D. T., Birnstiel M. L. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6099–6103. doi: 10.1073/pnas.89.13.6099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wu P., de Fiebre C. M., Millard W. J., Elmstrom K., Gao Y., Meyer E. M. Sendai virosomal infusion of an adeno-associated virus-derived construct containing neuropeptide Y into primary rat brain cultures. Neurosci Lett. 1995 May 5;190(2):73–76. doi: 10.1016/0304-3940(95)11503-o. [DOI] [PubMed] [Google Scholar]
  21. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gönczöl E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407–4411. doi: 10.1073/pnas.91.10.4407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. von der Leyen H. E., Gibbons G. H., Morishita R., Lewis N. P., Zhang L., Nakajima M., Kaneda Y., Cooke J. P., Dzau V. J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1137–1141. doi: 10.1073/pnas.92.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES